Search for: "CIPLA"
Results 81 - 100
of 202
Sorted by Relevance
|
Sort by Date
18 Feb 2009, 12:21 pm
However, on reviewing Erlotinib pre-grant opposition judgment we found Cipla's argument contradicting and fallacious. [read post]
3 Dec 2008, 9:41 pm
There is considerable likelihood that the decision may impact ongoing case in the Mumbai High Court between Roche and Cipla, possibly going in favor of Cipla. [read post]
4 Aug 2010, 9:11 am
Union of India/ Cipla hearing for the patent linkage matter (earlier blogged here) has been adjourned, at the request of one of the parties.The matter is now likely to be posted for hearing in the last week of November, 2010. [read post]
18 Nov 2019, 9:59 am
Matal v. [read post]
7 Mar 2013, 3:21 pm
The confirmed speakers for Pharma IPR 2013 taking place from 10-12 April at Holiday Inn Mumbai International Airport, Mumbai, India are as follows:- Jeffrey Alan Hovden, Partner, Robins, Kaplan, Miller & Ciresi (USA)- Sri K Sankaran, Partner, Winthrop & Weinstine (USA)- Rowan Forster, Director, Edward Nathan Sonnenbergs (South Africa)- Mariko Mimura, Director, Head of Legal/IP Japan, Novartis Holding (Japan)- Mia Qu, Partner, King & Wood Mallesons (China)- Alka Mehta, Head IPR,… [read post]
8 Jan 2011, 2:18 pm
The Application was refused after Bayer failed to overcome the pre-grant oppositions filed against the Application by generic manufacturers Cipla [read post]
21 Mar 2017, 11:45 pm
Cipla Industries Pvt Ltd in India, which involved the use of a well-known mark as trade name in respect to dissimilar goods.Monday miscellanyInternKat Tian Lu recaps IP news and events including the UKIPO call for views regarding illicit IPTV streaming devices.Around the IP BlogsInternKat Tian Lu covers the latest posts from some IP blogs.UK's IP Enforcement Framework-IPO Research Bid Opportunity (Update)IPkat Neil Wilkof announces the deadline for submitting applications to UKIPO… [read post]
31 Dec 2012, 1:52 pm
Cipla patent infringement suit was India’s first pharmaceutical patent litigation in the Post TRIPS era. [read post]
6 Apr 2013, 1:36 pm
Cipla judgement are available here and here. [read post]
6 Apr 2012, 2:00 pm
CIPLA Announcement.pdf (42.80 kb) [read post]
14 Jun 2012, 10:00 pm
Cipla Limited. [read post]
15 Apr 2009, 4:05 am
The Delhi Patent Office decided the pre-grant opposition in favor of Cipla Ltd. after it found that the applicant (Gilead) failed to provide any supportive evidence in the specification by means of comparative data or by way of examples which would have supported the inventive merit of Oseltamivir. [read post]
14 Mar 2012, 10:00 pm
Bayer has sued that company, Cipla, which is based in Mumbai, claiming patent infringement in a separate case that is pending. [read post]
14 Mar 2012, 10:00 pm
Bayer has sued that company, Cipla, which is based in Mumbai, claiming patent infringement in a separate case that is pending. [read post]
25 Sep 2009, 5:03 am
Consider Cipla's drug "Valcept", which is a generic version of Roche's patented anti-infective "Valcyte". [read post]
16 Feb 2009, 9:00 pm
In this week's call, regular panelists Jeremy Phillips, Shamnad Basheer and Duncan Bucknell are joined by special guests Nick Redfearn and Don Zuhn to discuss: Fallout from the World Trade Organisation dispute between China and the United States; Dr Reddy's, CIPLA, India, Brazil and the EU and the emerging controversy over seized pharmaceutical goods; TRIPS compliance and too much protection within a country; The infringement approach to goods… [read post]
14 Oct 2008, 4:52 pm
In January, Cipla launched the generic copy of Tarceva and was sued by Roche for infringement of patent in the Delhi High Court. [read post]
22 Jul 2009, 6:05 am
Mylan Inc (Global IP Watch) Lexapro (Escitalopram) – US: Forest and Sun settle Lexapro patent suit (Patent Docs) Lovenox (Enoxaparin) – US: Judge denies attorney fees to Sandoz in patent infringement dispute with Sanofi-Aventis (Patent Docs) Norflox-TZ (Norfloxacin) and Aerocort (Salbutamol) – India: Cipla attracts NPPA’s attention again – alleged overpricing of Salbutamol and Norfloxacin (Spicy IP) Ovide (Malathion) – US: Taro… [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
1 May 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Tarceva (Erlotinib) – India: Delhi High Court Appellate Bench holds in favour of Cipla against Roche in Tarceva patent litigation; Roche fined for ‘material suppression’ (Spicy IP) (PatLit) (Patent Circle) (Spicy IP) (Patent Circle) (Patent Circle) (GenericsWeb) Lovenox (Enoxaparin) – US: Supreme… [read post]
